nelfinavir has been researched along with Sarcoma, Kaposi in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anu, R; Cauda, R; De Donatis, GM; Gillet, JP; Gottesman, MM; Handley, M; Lucia, MB; Wu, CP | 1 |
Horneff, G; Megahed, M; Niehues, T; Schroten, H; Wahn, V | 1 |
2 other study(ies) available for nelfinavir and Sarcoma, Kaposi
Article | Year |
---|---|
Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.
Topics: Antibiotics, Antineoplastic; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Oligopeptides; Pyridines; Pyrimidinones; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; Sarcoma, Kaposi; Treatment Outcome | 2011 |
Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Child, Preschool; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Lamivudine; Nelfinavir; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Treatment Outcome; Zidovudine | 1999 |